Chemistry-Biochemistry-Biology Interface (CBBI) Program at Notre Dame

摘要 圣母大学的化学-生物化学-生物学接口(CBBI)课程是一个 建立了由NIH资助的计划，支持培训不同的科学家库，这些科学家 在化学和生物相关学科的交界处进行多学科研究。CBBI的目标是 该计划是培养在化学和生物学领域有效工作的博士科学家，他们是 能说两门或两门以上学科的语言。CBBI项目建立了卓越的培训 为我们的博士前实习生提供环境。自2007年以来，我们已经培训了84名学生，其中57名已经完成 平均5.14年获得博士学位(过去10年，CBBI学员获得博士学位的时间为4.98) 其中19人仍在训练中。在这84人中，有16人是代表不足的少数民族，其中10人已经 获得博士学位。我们的84名学员有362种出版物，其中159种是第一作者出版物。这 代表每名受训人员发表4.3种出版物和每名受训人员发表1.9种第一作者出版物。这16个URM已经制作了 79种出版物，其中31种是第一作者出版物；这意味着每URM有4.9种出版物和1.9种第一作者出版物- 每个URM的作者出版物。在过去的14年里，我们的自然流失率一直很低，84人中只有8人 未完成博士学位的学员(9.5%)。CBBI计划的主要亮点是：1)大型和 高素质候选人的多样化；2)合作和多学科研究的良好记录 实习生和导师；3)担任研究导师和经验丰富的不同教职员工群体， 富有成效，并由联邦政府资助；4)在外部其他领域进行密集的、跨学科的研究实习 导师实验室；5)补充培训的多学科研讨会；6)个人和小组会议 与实习生；7)CBBI年度研讨会，以口头和海报演示化学- 生物界面；8)项目管理，有在化学-化学领域培训学生的既定记录 生物学接口；9)培训计划的持续评估和细化的计划和机制； 10)专业发展和职业安置；11)出色的研究设施；12)强大的 机构承诺。我们建议继续培训具有解决问题的技能和专业知识的博士科学家 挑战生物医学问题，不分学科。巴黎圣母大学热情高涨 支持这一培训计划，并将继续为CBBI计划提供慷慨的奖学金 以及追加资源，包括所有受训人员在续期供资时的研究实习费用 被美国国立卫生研究院。

Abstract The Chemistry-Biochemistry-Biology Interface (CBBI) Program at the University of Notre Dame is an established NIH-funded program that supports the training of diverse pool of scientists who conduct multidisciplinary research at the interface of chemistry and biology-related disciplines. The goal of the CBBI Program is to produce PhD scientists who work effectively at the interface of chemistry and biology and who are able to speak the language of two or more disciplines. The CBBI Program has established an outstanding training environment for our predoctoral trainees. Since 2007 we have trained 84 students, 57 of whom have completed PhD degrees in an average of 5.14 years (time to PhD degree from CBBI trainees is 4.98 in the past 10 years) with 19 still in training. Of these 84, 16 are underrepresented minorities (URMs), 10 of whom have already received PhD degrees. Our 84 trainees have 362 publications, of which 159 are first-author publications. This represents 4.3 publications per trainee and 1.9 first-author publications per trainee. The 16 URMs have produced 79 publications, of which 31 are first-author publications; this represents 4.9 publications per URM and 1.9 first- author publications per URM. During the past 14 years, our attrition rate has been low, with only eight of 84 trainees (9.5%) who did not complete a PhD degree. The key highlights of the CBBI Program are: 1) a large and diverse pool of highly qualified candidates; 2) a strong track record of collaborative and multidisciplinary research by both trainees and mentors; 3) a diverse faculty group that serves as research mentors and are experienced, productive, and federally-funded; 4) an intensive, cross-disciplinary research internship in the other field outside the mentor’s laboratory; 5) multidisciplinary seminars that supplement training; 6) individual and group meetings with trainees; 7) the annual CBBI symposium that features both oral and poster presentations at the chemistry- biology interface; 8) program administration with an established track record of training students at the chemistry- biology interface; 9) a plan and mechanism for continuous evaluation and refinement of the training program; 10) professional development and career placement; 11) outstanding research facilities; and 12) a strong institutional commitment. We propose to continue to train PhD scientists with the skills and expertise to solve challenging biomedical problems, regardless of discipline. The University of Notre Dame enthusiastically supports this training program, and will continue to provide a generous fellowship match to the CBBI Program and additional resources, including the cost of the research internship for all trainees, upon renewal of funding by the NIH.